CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Alternative technologies

3.2.1. Intrauterine insemination (IUI) technique

3.2.1.1. Benefits of IUI
3.2.1.2. Difference between IUI and IVF techniques

3.2.2. Gamete intra-fallopian transfer (GIFT) technique

3.2.2.1. Differences between GIFT and IVF technique

3.2.3. Zygote intrafallopian transfer (ZIFT) technique

3.2.3.1. Differences between ZIFT and IVF technique

3.3. REPLACING IVF PROCEDURES BY FERTILITY DRUGS AND SURGERIES

3.3.1. Female infertility treatments
3.3.2. Risks associated with fertility drugs
3.3.3. Male infertility treatment

3.4. COST OF IVF PROCEDURES
3.5. ROLE OF DONORS IN THE IVF MARKET

3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research

3.6. Surrogacy

3.6.1. Legal issues

3.7. IVF TRENDS IN SAME SEX COUPLES

3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In vitro fertilization

3.8. ADVANCED IVF TECHNOLOGIES

3.8.1. Capsule IVF
3.8.2. Three parent IVF

3.8.2.1. Ethical concerns

3.8.3. Mini IVF

3.8.3.1. Advantages
3.8.3.2. Drawbacks

3.8.4. Embryo scope

3.8.4.1. Advantages
3.8.4.2. PICSI

3.9. FERTILITY TREATMENT AND GENDER SELECTION

3.9.1. Methods of sex selection

3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)

3.9.1.3.1. Ethical and legal issues

3.10. METABOLOMICS IN EMBRYO SCREENING METHODS
3.11. APPLICATION OF STEM CELLS IN IVF
3.12. IVF AND RESOURCE-POOR COUNTRIES
3.13. KEY FINDINGS

3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies

3.14. PORTERS FIVE FORCES ANALYSIS

3.14.1. High competition and large number reduces the power of suppliers
3.14.2. Scattered nature and large count of end users moderate the buyer power
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes

3.15. VALUE CHAIN ANALYSIS
3.16. PATENT ANALYSIS

3.16.1. Patent analysis, by year
3.16.2. Patents analysis, by country

3.17. REGULATORY ISSUES AND LEGISLATIONS
3.18. INSURANCE REIMBURSEMENT SCENARIO
3.19. CLINICAL TRIAL
3.20. Drivers

3.20.1. Delayed pregnancies in women
3.20.2. Increase in global infertility rates
3.20.3. Technological advancement in IVF devices
3.20.4. Increase in gamete donations
3.20.5. Increase in disposable income
3.20.6. Increase in success rates
3.20.7. Surge in healthcare expenditure worldwide

3.21. Restraints

3.21.1. Cost constraints
3.21.2. Complications associated with IVF treatment
3.21.3. Low awareness level

3.22. Opportunities

3.22.1. Fertility tourism
3.22.2. Growth opportunities in the emerging markets
3.22.3. Increase in number of fertility clinics
3.22.4. Rise in same sex marriage

3.23. Impact analyses

CHAPTER 4: IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Instruments

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type

4.2.2.1. Sperm separation system

4.2.2.1.1. Market size and forecast

4.2.2.2. Cryosystem

4.2.2.2.1. Market size and forecast

4.2.2.3. Incubator

4.2.2.3.1. Market size and forecast

4.2.2.4. Imaging system

4.2.2.4.1. Market size and forecast

4.2.2.5. Ovum aspiration pump

4.2.2.5.1. Market size and forecast

4.2.2.6. Cabinet (workstation)

4.2.2.6.1. Market size and forecast

4.2.2.7. Micromanipulator system

4.2.2.7.1. Market size and forecast

4.2.2.8. Others

4.2.2.8.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Accessories & disposables

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Reagent & Media

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. Cryopreservation media

4.4.2.1.1. Market size and forecast

4.4.2.2. Semen processing media

4.4.2.2.1. Market size and forecast

4.4.2.3. Ovum processing media

4.4.2.3.1. Market size and forecast

4.4.2.4. Embryo culture media

4.4.2.4.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

CHAPTER 5: IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY

5.1. Overview

5.1.1. Market size and forecast

5.2. FRESH EMBRYO IVF

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. FROZEN EMBRYO IVF

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. DONOR EMBRYO IVF

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: IVF DEVICES AND CONSUMABLES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. FERTILITY CLINICS

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. HOSPITALS

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. SURGICAL CENTERS

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

6.5. CLINICAL RESEARCH INSTITUTES

6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: IVF DEVICES AND CONSUMABLES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. IVF devices and consumables market, by product
7.2.2.1.2. U.S. IVF devices and consumables market, by technology
7.2.2.1.3. U.S. IVF devices and consumables market, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada IVF devices and consumables market, by product
7.2.2.2.2. Canada IVF devices and consumables market, by technology
7.2.2.2.3. Canada IVF devices and consumables market, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico IVF devices and consumables market, by product
7.2.2.3.2. Mexico IVF devices and consumables market, by technology
7.2.2.3.3. Mexico IVF devices and consumables market, by end user

7.2.3. North America IVF devices and consumables market, by product
7.2.4. North America IVF devices and consumables market, by technology
7.2.5. North America IVF devices and consumables market, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany IVF devices and consumables market, by product
7.3.2.1.2. Germany IVF devices and consumables market, by technology
7.3.2.1.3. Germany IVF devices and consumables market, by end user

7.3.2.2. France

7.3.2.2.1. France IVF devices and consumables market, by product
7.3.2.2.2. France IVF devices and consumables market, by technology
7.3.2.2.3. France IVF devices and consumables market, by end user

7.3.2.3. UK

7.3.2.3.1. UK IVF devices and consumables market, by product
7.3.2.3.2. UK IVF devices and consumables market, by technology
7.3.2.3.3. UK IVF devices and consumables market, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy IVF devices and consumables market, by product
7.3.2.4.2. Italy IVF devices and consumables market, by technology
7.3.2.4.3. Italy IVF devices and consumables market, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain IVF devices and consumables market, by product
7.3.2.5.2. Spain IVF devices and consumables market, by technology
7.3.2.5.3. Spain IVF devices and consumables market, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe IVF devices and consumables market, by product
7.3.2.6.2. Rest of Europe IVF devices and consumables market, by technology
7.3.2.6.3. Rest of Europe IVF devices and consumables market, by end user

7.3.3. Europe IVF devices and consumables market, by product
7.3.4. Europe IVF devices and consumables market, by technology
7.3.5. Europe IVF devices and consumables market, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan IVF devices and consumables market, by product
7.4.2.1.2. Japan IVF devices and consumables market, by technology
7.4.2.1.3. Japan IVF devices and consumables market, by end user

7.4.2.2. China

7.4.2.2.1. China IVF devices and consumables market, by product
7.4.2.2.2. China IVF devices and consumables market, by technology
7.4.2.2.3. China IVF devices and consumables market, by end user

7.4.2.3. Australia

7.4.2.3.1. Australia IVF devices and consumables market, by product
7.4.2.3.2. Australia IVF devices and consumables market, by technology
7.4.2.3.3. Australia IVF devices and consumables market, by end user

7.4.2.4. India

7.4.2.4.1. India IVF devices and consumables market, by product
7.4.2.4.2. India IVF devices and consumables market, by technology
7.4.2.4.3. India IVF devices and consumables market, by end user

7.4.2.5. Rest of Asia-Pacific

7.4.2.5.1. Rest of Asia-Pacific IVF devices and consumables market, by product
7.4.2.5.2. Rest of Asia-Pacific IVF devices and consumables market, by technology
7.4.2.5.3. Rest of Asia-Pacific IVF devices and consumables market, by end user

7.4.3. Asia-Pacific IVF devices and consumables market, by product
7.4.4. Asia-Pacific IVF devices and consumables market, by technology
7.4.5. Asia-Pacific IVF devices and consumables market, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country

7.5.2.1. Latin America

7.5.2.1.1. Latin American IVF devices and consumables market, by product
7.5.2.1.2. Latin American IVF devices and consumables market, by technology
7.5.2.1.3. Latin American IVF devices and consumables market, by end user

7.5.2.2. Middle East

7.5.2.2.1. Middle East IVF devices and consumables market, by product
7.5.2.2.2. Middle East IVF devices and consumables market, by technology
7.5.2.2.3. Middle East IVF devices and consumables market, by end user

7.5.2.3. Africa

7.5.2.3.1. Africa IVF devices and consumables market, by product
7.5.2.3.2. Africa IVF devices and consumables market, by technology
7.5.2.3.3. Africa IVF devices and consumables market, by end user

7.5.3. LAMEA IVF devices and consumables market, by product
7.5.4. LAMEA IVF devices and consumables market, by technology
7.5.5. LAMEA IVF devices and consumables market, by end user

CHAPTER 8: COMPONY PROFILES

8.1. Cook Medical Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. SWOT analysis

8.2. The Cooper Companies, Inc. (CooperSurgical, Inc.)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.2.7. SWOT analysis

8.3. Merck KGaA (EMD Serono, Inc.)

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.3.7. SWOT analysis

8.4. Genea Biomedx

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Key strategic moves and developments
8.4.5. SWOT analysis

8.5. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.5.7. SWOT analysis

8.6. Ovascience Inc.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.6.7. SWOT analysis

8.7. Oxford Gene Technology

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.7.6. SWOT analysis

8.8. Progyny Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.8.5. SWOT analysis

8.9. Thermo Fisher Scientific, Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. SWOT analysis

8.10. Vitrolife AB

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.10.6. SWOT analysis